Open Label Phase II Immunotherapy Trial of Inoperable Pancreatic Cancer
Latest Information Update: 05 Nov 2021
At a glance
- Drugs V3 P (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Immunitor
Most Recent Events
- 29 May 2017 New trial record